资讯
Lantern Pharma advances pediatric CNS cancer treatment with FDA guidance on LP-184 trial, targeting rare tumors and enhancing ...
TipRanks on MSN
AstraZeneca’s Phase III Trial on AZD0780: A Potential Game-Changer in Cardiovascular ...
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase III clinical trial ...
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase III clinical trial ...
Anju Software today announced clinexa, an AI ecosystem of virtual assistants that transforms clinical protocols into ...
The IEEE1284 compliant parallel port controller supports faster data rates up to 2.0Mbytes/sec. It supports Nibble mode, Byte Mode, EPP, and ECP. Auto ...
Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...
Arabian Post on MSN
AI-Powered Drug Design Slashes Timelines and Spurs Ethical Shift
Dubai Pharmaceutical developers are making headway with artificial intelligence tools to model drug absorption, distribution, and toxicity in human-relevant systems. This shift supports the U. S. Food ...
Outstanding Treasury securities closed June at $28.5 TN. Agency Securities have more than tripled to $12.4 TN. The overheated ...
Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.
One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today ...
Detailed price information for Pasithea Therapeutics Corp (KTTA-Q) from The Globe and Mail including charting and trades.
Verywell Health on MSN
Whey Protein vs. Pea Protein: Which Is Better for You?
Pea protein and whey protein provide similar nutrition and health benefits, including supporting weight loss and muscle gain.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果